Healthcare - Sector
BCRX is currently covered by 9 analysts with an average price target of $21.64. This is a potential upside of $14.42 (199.72%) from yesterday's end of day stock price of $7.22.
Our record on BCRX covers 19 analysts since 2008; 9 cover it today. Of the 187 price targets those analysts set on BCRX, 96 were reached (51%). The highest performance score on BCRX belongs to Liisa Bayko of Evercore: 4.33, with 9 of 12 targets met in 683 days on average. The latest calls: Laura Chico of Wedbush cut the target to $17 from $20 with a Buy rating on 5 Nov 2026; Jessica Fye of JPMorgan raised the target to $13 from $12 with a Hold rating on 30 Sep 2026; Brian Abrahams of RBC cut the target to $11 from $14 with a Buy rating on 10 Sep 2026. Figures as of 18 Nov 2026.
BioCryst Pharmaceuticals's activity chart (see below) currently has 241 price targets and 204 ratings on display. The stock rating distribution of BCRX is 90% BUY and 10% HOLD.
Analysts' price targets on this stock were met 48.81% of the time, taking 284.85 days on average.
Highest price target for BCRX is $32, Lowest price target is $11, average price target is $21.64.
Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 05-Nov-2026. First documented stock forecast 31-Jul-2013.
Currently out of the existing stock ratings of BCRX, 18 are a BUY (90%), 2 are a HOLD (10%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Jun-2025
$17
$9.78 (135.46%)
$20
16 days ago
(05-Nov-2026)
0/6 (0%)
$9.37 (122.80%)
Hold Since 13-Jul-2026
$13
$5.78 (80.06%)
$12
1 months 22 days ago
(30-Sep-2026)
6/9 (66.67%)
$4.67 (56.06%)
234
Buy Since 25-Sep-2023
$11
$3.78 (52.35%)
$14
2 months 11 days ago
(10-Sep-2026)
28/35 (80%)
$2.71 (32.69%)
353
Buy Since 20-Apr-2023
$16
$8.78 (121.61%)
$16
2 months 13 days ago
(08-Sep-2026)
5/20 (25%)
$6.93 (76.41%)
334
Buy Since 03-Nov-2023
$17
$9.78 (135.46%)
$15
4 months 22 days ago
(30-Jun-2026)
9/12 (75%)
$7 (70.00%)
344
What is BCRX (BioCryst Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on BCRX (BioCryst Pharmaceuticals)?
Which analyst has the most public recommendations on BCRX (BioCryst Pharmaceuticals)?
Which analyst is the currently most bullish on BCRX (BioCryst Pharmaceuticals)?
Which analyst is the currently most reserved on BCRX (BioCryst Pharmaceuticals)?